[1] [1] Roy S, Kabach M, Patel DB, et al. Radial artery access complications: prevention, diagnosis and management[J]. Cardiovasc Revasc Med, 2022, 40: 163-171.

[3] [3] Wu Y, Wang L, Zhan Y, et al. The expression of SAH, IL-1, Hcy, TNF- and BDNF in coronary heart disease and its relationship with the severity of coronary stenosis[J]. BMC Cardiovasc Disord, 2022, 22(1): 101.

[4] [4] Yang Y, Wang J, Wai Si Ding AJGL, et al. Serum total bilirubin and long-term prognosis of patients with new-onset non-ST elevation myocardial infarction: a cohort study[J]. BMC Cardiovasc Disord, 2022, 22(1): 165.

[9] [9] Huang Z, Cao B, Du X, et al. Prognostic value of coronary CTA-based classifications for predicting major events without obstructive coronary artery disease[J]. Sci Rep, 2023, 13(1): 10635.

[10] [10] Liu W, Weng S, Liu H, et al. Serum soluble TREM2 is an independent biomarker associated with coronary heart disease[J]. Clin Chim Acta, 2023, 548: 117499.

[11] [11] Zhang Q, Wu C, Tan X, et al. Homocysteine facilitates the formation of carotid atherosclerotic plaque through inflammatory and noninflammatory mechanisms[J]. Metab Syndr Relat Disord, 2024, 22(5): 365-371.

[14] [14] Zhang Z, Wang L, Zhan Y, et al. Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease[J]. BMC Cardiovasc Disord, 2022, 22(1): 215.

[15] [15] Li XL, Zhao CR, Pan CL, et al. Role of bilirubin in the prognosis of coronary artery disease and its relationship with cardiovascular risk factors: a meta-analysis[J]. BMC Cardiovasc Disord, 2022, 22(1): 458.